Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. ENZN Peers
See (ENZN) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ENZN | $0.09 | +0.83% | 6.35M | -8.55 | -$0.01 | N/A |
| NONOF | $64.91 | +0.64% | 288.15B | 18.39 | $3.53 | +2.55% |
| CSLLY | $76.65 | +0.58% | 148.46B | 27.97 | $2.74 | +1.73% |
| CMXHF | $146.50 | -3.14% | 70.94B | 26.88 | $5.45 | +1.80% |
| ARGNF | $562.00 | N/A | 34.32B | 34.25 | $16.41 | N/A |
| UCBJY | $85.81 | -1.89% | 33.15B | 27.86 | $3.08 | +0.63% |
| UCBJF | $170.75 | -2.18% | 32.45B | 27.58 | $6.19 | +0.72% |
| ODTC | $22,005.00 | +29.44% | 24.14B | -0.08 | -$268,995.00 | N/A |
| WXXWY | $6.01 | +1.86% | 12.21B | 27.32 | $0.22 | N/A |
| WXIBF | $3.00 | N/A | 12.19B | 27.27 | $0.11 | N/A |
Stock Comparison
ENZN vs NONOF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, NONOF has a market cap of 288.15B. Regarding current trading prices, ENZN is priced at $0.09, while NONOF trades at $64.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas NONOF's P/E ratio is 18.39. In terms of profitability, ENZN's ROE is -0.00%, compared to NONOF's ROE of +0.85%. Regarding short-term risk, ENZN is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs CSLLY Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, CSLLY has a market cap of 148.46B. Regarding current trading prices, ENZN is priced at $0.09, while CSLLY trades at $76.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas CSLLY's P/E ratio is 27.97. In terms of profitability, ENZN's ROE is -0.00%, compared to CSLLY's ROE of +0.15%. Regarding short-term risk, ENZN is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs CMXHF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, CMXHF has a market cap of 70.94B. Regarding current trading prices, ENZN is priced at $0.09, while CMXHF trades at $146.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas CMXHF's P/E ratio is 26.88. In terms of profitability, ENZN's ROE is -0.00%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, ENZN is less volatile compared to CMXHF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs ARGNF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, ARGNF has a market cap of 34.32B. Regarding current trading prices, ENZN is priced at $0.09, while ARGNF trades at $562.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas ARGNF's P/E ratio is 34.25. In terms of profitability, ENZN's ROE is -0.00%, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, ENZN is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs UCBJY Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, UCBJY has a market cap of 33.15B. Regarding current trading prices, ENZN is priced at $0.09, while UCBJY trades at $85.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas UCBJY's P/E ratio is 27.86. In terms of profitability, ENZN's ROE is -0.00%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, ENZN is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs UCBJF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, UCBJF has a market cap of 32.45B. Regarding current trading prices, ENZN is priced at $0.09, while UCBJF trades at $170.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas UCBJF's P/E ratio is 27.58. In terms of profitability, ENZN's ROE is -0.00%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, ENZN is less volatile compared to UCBJF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs ODTC Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, ODTC has a market cap of 24.14B. Regarding current trading prices, ENZN is priced at $0.09, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas ODTC's P/E ratio is -0.08. In terms of profitability, ENZN's ROE is -0.00%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, ENZN is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs WXXWY Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, WXXWY has a market cap of 12.21B. Regarding current trading prices, ENZN is priced at $0.09, while WXXWY trades at $6.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas WXXWY's P/E ratio is 27.32. In terms of profitability, ENZN's ROE is -0.00%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, ENZN is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs WXIBF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, WXIBF has a market cap of 12.19B. Regarding current trading prices, ENZN is priced at $0.09, while WXIBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas WXIBF's P/E ratio is 27.27. In terms of profitability, ENZN's ROE is -0.00%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, ENZN is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs GNMSF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, GNMSF has a market cap of 11.61B. Regarding current trading prices, ENZN is priced at $0.09, while GNMSF trades at $188.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas GNMSF's P/E ratio is 10.26. In terms of profitability, ENZN's ROE is -0.00%, compared to GNMSF's ROE of +0.24%. Regarding short-term risk, ENZN is less volatile compared to GNMSF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs IVBXF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, IVBXF has a market cap of 9.80B. Regarding current trading prices, ENZN is priced at $0.09, while IVBXF trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas IVBXF's P/E ratio is -594.00. In terms of profitability, ENZN's ROE is -0.00%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, ENZN is less volatile compared to IVBXF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs SBMFF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, SBMFF has a market cap of 8.82B. Regarding current trading prices, ENZN is priced at $0.09, while SBMFF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas SBMFF's P/E ratio is 49.30. In terms of profitability, ENZN's ROE is -0.00%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, ENZN is less volatile compared to SBMFF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs SBHMY Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, SBHMY has a market cap of 8.48B. Regarding current trading prices, ENZN is priced at $0.09, while SBHMY trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas SBHMY's P/E ratio is 32.69. In terms of profitability, ENZN's ROE is -0.00%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, ENZN is less volatile compared to SBHMY. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs TLPPF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, TLPPF has a market cap of 5.85B. Regarding current trading prices, ENZN is priced at $0.09, while TLPPF trades at $17.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas TLPPF's P/E ratio is 192.22. In terms of profitability, ENZN's ROE is -0.00%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, ENZN is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs ABCZF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, ABCZF has a market cap of 5.12B. Regarding current trading prices, ENZN is priced at $0.09, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, ENZN's ROE is -0.00%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, ENZN is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs INCPF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, INCPF has a market cap of 4.88B. Regarding current trading prices, ENZN is priced at $0.09, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas INCPF's P/E ratio is -108.67. In terms of profitability, ENZN's ROE is -0.00%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, ENZN is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs AKBLF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, AKBLF has a market cap of 4.75B. Regarding current trading prices, ENZN is priced at $0.09, while AKBLF trades at $21.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas AKBLF's P/E ratio is 38.13. In terms of profitability, ENZN's ROE is -0.00%, compared to AKBLF's ROE of +0.16%. Regarding short-term risk, ENZN is less volatile compared to AKBLF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs LABFF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, LABFF has a market cap of 4.63B. Regarding current trading prices, ENZN is priced at $0.09, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas LABFF's P/E ratio is 28.95. In terms of profitability, ENZN's ROE is -0.00%, compared to LABFF's ROE of +0.39%. Regarding short-term risk, ENZN is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs ZLDPF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, ZLDPF has a market cap of 4.40B. Regarding current trading prices, ENZN is priced at $0.09, while ZLDPF trades at $62.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas ZLDPF's P/E ratio is -25.28. In terms of profitability, ENZN's ROE is -0.00%, compared to ZLDPF's ROE of -0.15%. Regarding short-term risk, ENZN is less volatile compared to ZLDPF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs CAMRF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, CAMRF has a market cap of 3.82B. Regarding current trading prices, ENZN is priced at $0.09, while CAMRF trades at $65.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas CAMRF's P/E ratio is 88.04. In terms of profitability, ENZN's ROE is -0.00%, compared to CAMRF's ROE of +0.14%. Regarding short-term risk, ENZN is less volatile compared to CAMRF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs SHJBF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, SHJBF has a market cap of 3.72B. Regarding current trading prices, ENZN is priced at $0.09, while SHJBF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas SHJBF's P/E ratio is -7.30. In terms of profitability, ENZN's ROE is -0.00%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, ENZN is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs REGMF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, REGMF has a market cap of 3.32B. Regarding current trading prices, ENZN is priced at $0.09, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas REGMF's P/E ratio is -13.32. In terms of profitability, ENZN's ROE is -0.00%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, ENZN is less volatile compared to REGMF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs GNNSF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, GNNSF has a market cap of 2.90B. Regarding current trading prices, ENZN is priced at $0.09, while GNNSF trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas GNNSF's P/E ratio is -16.94. In terms of profitability, ENZN's ROE is -0.00%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, ENZN is less volatile compared to GNNSF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs TKBIF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, TKBIF has a market cap of 2.79B. Regarding current trading prices, ENZN is priced at $0.09, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, ENZN's ROE is -0.00%, compared to TKBIF's ROE of N/A. Regarding short-term risk, ENZN is more volatile compared to TKBIF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs MPSYF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, MPSYF has a market cap of 2.76B. Regarding current trading prices, ENZN is priced at $0.09, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, ENZN's ROE is -0.00%, compared to MPSYF's ROE of +7.43%. Regarding short-term risk, ENZN is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs ASPHF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, ASPHF has a market cap of 2.24B. Regarding current trading prices, ENZN is priced at $0.09, while ASPHF trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas ASPHF's P/E ratio is -35.83. In terms of profitability, ENZN's ROE is -0.00%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, ENZN is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs BVNKF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, BVNKF has a market cap of 2.09B. Regarding current trading prices, ENZN is priced at $0.09, while BVNKF trades at $26.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas BVNKF's P/E ratio is 14.03. In terms of profitability, ENZN's ROE is -0.00%, compared to BVNKF's ROE of +0.09%. Regarding short-term risk, ENZN is less volatile compared to BVNKF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs TRSBF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, TRSBF has a market cap of 1.95B. Regarding current trading prices, ENZN is priced at $0.09, while TRSBF trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas TRSBF's P/E ratio is 9.20. In terms of profitability, ENZN's ROE is -0.00%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, ENZN is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs BTTAY Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, BTTAY has a market cap of 1.92B. Regarding current trading prices, ENZN is priced at $0.09, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas BTTAY's P/E ratio is 65.49. In terms of profitability, ENZN's ROE is -0.00%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, ENZN is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs BVNRY Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, BVNRY has a market cap of 1.85B. Regarding current trading prices, ENZN is priced at $0.09, while BVNRY trades at $7.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas BVNRY's P/E ratio is 12.60. In terms of profitability, ENZN's ROE is -0.00%, compared to BVNRY's ROE of +0.09%. Regarding short-term risk, ENZN is less volatile compared to BVNRY. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs MEOBF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, MEOBF has a market cap of 1.82B. Regarding current trading prices, ENZN is priced at $0.09, while MEOBF trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas MEOBF's P/E ratio is -15.89. In terms of profitability, ENZN's ROE is -0.00%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, ENZN is less volatile compared to MEOBF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs GENSF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, GENSF has a market cap of 1.78B. Regarding current trading prices, ENZN is priced at $0.09, while GENSF trades at $27.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas GENSF's P/E ratio is -338.75. In terms of profitability, ENZN's ROE is -0.00%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, ENZN is less volatile compared to GENSF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs PPTDF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, PPTDF has a market cap of 1.75B. Regarding current trading prices, ENZN is priced at $0.09, while PPTDF trades at $13.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas PPTDF's P/E ratio is 16.91. In terms of profitability, ENZN's ROE is -0.00%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, ENZN is less volatile compared to PPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs BRCTF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, BRCTF has a market cap of 1.62B. Regarding current trading prices, ENZN is priced at $0.09, while BRCTF trades at $18.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas BRCTF's P/E ratio is -87.38. In terms of profitability, ENZN's ROE is -0.00%, compared to BRCTF's ROE of -0.19%. Regarding short-term risk, ENZN is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs BIESF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, BIESF has a market cap of 1.60B. Regarding current trading prices, ENZN is priced at $0.09, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas BIESF's P/E ratio is 43.24. In terms of profitability, ENZN's ROE is -0.00%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, ENZN is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs ONTTF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, ONTTF has a market cap of 1.58B. Regarding current trading prices, ENZN is priced at $0.09, while ONTTF trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas ONTTF's P/E ratio is -7.84. In terms of profitability, ENZN's ROE is -0.00%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, ENZN is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs GLPGF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, GLPGF has a market cap of 1.48B. Regarding current trading prices, ENZN is priced at $0.09, while GLPGF trades at $22.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas GLPGF's P/E ratio is -7.25. In terms of profitability, ENZN's ROE is -0.00%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, ENZN is less volatile compared to GLPGF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs PHMMF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, PHMMF has a market cap of 1.42B. Regarding current trading prices, ENZN is priced at $0.09, while PHMMF trades at $80.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas PHMMF's P/E ratio is 63.21. In terms of profitability, ENZN's ROE is -0.00%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, ENZN is less volatile compared to PHMMF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs CSBTF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, CSBTF has a market cap of 1.15B. Regarding current trading prices, ENZN is priced at $0.09, while CSBTF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas CSBTF's P/E ratio is -250.00. In terms of profitability, ENZN's ROE is -0.00%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, ENZN is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs NURPF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, NURPF has a market cap of 1.02B. Regarding current trading prices, ENZN is priced at $0.09, while NURPF trades at $8.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas NURPF's P/E ratio is 11.63. In terms of profitability, ENZN's ROE is -0.00%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, ENZN is less volatile compared to NURPF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs ASCLF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, ASCLF has a market cap of 821.88M. Regarding current trading prices, ENZN is priced at $0.09, while ASCLF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas ASCLF's P/E ratio is -21.19. In terms of profitability, ENZN's ROE is -0.00%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, ENZN is less volatile compared to ASCLF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs CSPHF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, CSPHF has a market cap of 702.96M. Regarding current trading prices, ENZN is priced at $0.09, while CSPHF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas CSPHF's P/E ratio is -51.80. In terms of profitability, ENZN's ROE is -0.00%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, ENZN is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs PHGUF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, PHGUF has a market cap of 621.12M. Regarding current trading prices, ENZN is priced at $0.09, while PHGUF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas PHGUF's P/E ratio is -45.65. In terms of profitability, ENZN's ROE is -0.00%, compared to PHGUF's ROE of -0.05%. Regarding short-term risk, ENZN is less volatile compared to PHGUF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs BPMUF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, BPMUF has a market cap of 582.74M. Regarding current trading prices, ENZN is priced at $0.09, while BPMUF trades at $47.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas BPMUF's P/E ratio is 6.79. In terms of profitability, ENZN's ROE is -0.00%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, ENZN is less volatile compared to BPMUF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs INRLF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, INRLF has a market cap of 543.23M. Regarding current trading prices, ENZN is priced at $0.09, while INRLF trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas INRLF's P/E ratio is -36.11. In terms of profitability, ENZN's ROE is -0.00%, compared to INRLF's ROE of -0.06%. Regarding short-term risk, ENZN is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs SOLTF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, SOLTF has a market cap of 531.31M. Regarding current trading prices, ENZN is priced at $0.09, while SOLTF trades at $5.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas SOLTF's P/E ratio is -32.83. In terms of profitability, ENZN's ROE is -0.00%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, ENZN is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs CYDY Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, CYDY has a market cap of 514.74M. Regarding current trading prices, ENZN is priced at $0.09, while CYDY trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas CYDY's P/E ratio is -20.88. In terms of profitability, ENZN's ROE is -0.00%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, ENZN is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs IVEVF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, IVEVF has a market cap of 505.87M. Regarding current trading prices, ENZN is priced at $0.09, while IVEVF trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas IVEVF's P/E ratio is -1.05. In terms of profitability, ENZN's ROE is -0.00%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, ENZN is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs CLTEF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, CLTEF has a market cap of 504.72M. Regarding current trading prices, ENZN is priced at $0.09, while CLTEF trades at $7.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas CLTEF's P/E ratio is -7.06. In terms of profitability, ENZN's ROE is -0.00%, compared to CLTEF's ROE of -0.61%. Regarding short-term risk, ENZN is more volatile compared to CLTEF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs VBIZF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, VBIZF has a market cap of 472.97M. Regarding current trading prices, ENZN is priced at $0.09, while VBIZF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas VBIZF's P/E ratio is 22.70. In terms of profitability, ENZN's ROE is -0.00%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, ENZN is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs SNBIF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, SNBIF has a market cap of 471.70M. Regarding current trading prices, ENZN is priced at $0.09, while SNBIF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas SNBIF's P/E ratio is -22.59. In terms of profitability, ENZN's ROE is -0.00%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, ENZN is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs CKDXF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, CKDXF has a market cap of 470.61M. Regarding current trading prices, ENZN is priced at $0.09, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, ENZN's ROE is -0.00%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, ENZN is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs AAVXF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, AAVXF has a market cap of 457.38M. Regarding current trading prices, ENZN is priced at $0.09, while AAVXF trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas AAVXF's P/E ratio is -2.27. In terms of profitability, ENZN's ROE is -0.00%, compared to AAVXF's ROE of -1.10%. Regarding short-term risk, ENZN is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs TBGNF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, TBGNF has a market cap of 433.72M. Regarding current trading prices, ENZN is priced at $0.09, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, ENZN's ROE is -0.00%, compared to TBGNF's ROE of N/A. Regarding short-term risk, ENZN is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs BXPHF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, BXPHF has a market cap of 429.87M. Regarding current trading prices, ENZN is priced at $0.09, while BXPHF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas BXPHF's P/E ratio is -22.00. In terms of profitability, ENZN's ROE is -0.00%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, ENZN is less volatile compared to BXPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs HBMHF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, HBMHF has a market cap of 407.69M. Regarding current trading prices, ENZN is priced at $0.09, while HBMHF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas HBMHF's P/E ratio is 16.07. In terms of profitability, ENZN's ROE is -0.00%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, ENZN is more volatile compared to HBMHF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs PTCHF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, PTCHF has a market cap of 396.31M. Regarding current trading prices, ENZN is priced at $0.09, while PTCHF trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas PTCHF's P/E ratio is 7.86. In terms of profitability, ENZN's ROE is -0.00%, compared to PTCHF's ROE of -0.22%. Regarding short-term risk, ENZN is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs NWBO Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, NWBO has a market cap of 390.17M. Regarding current trading prices, ENZN is priced at $0.09, while NWBO trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas NWBO's P/E ratio is -4.01. In terms of profitability, ENZN's ROE is -0.00%, compared to NWBO's ROE of +1.24%. Regarding short-term risk, ENZN is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs CLVLY Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, CLVLY has a market cap of 350.87M. Regarding current trading prices, ENZN is priced at $0.09, while CLVLY trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas CLVLY's P/E ratio is 14.00. In terms of profitability, ENZN's ROE is -0.00%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, ENZN is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs CLVLF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, CLVLF has a market cap of 348.36M. Regarding current trading prices, ENZN is priced at $0.09, while CLVLF trades at $6.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas CLVLF's P/E ratio is 14.18. In terms of profitability, ENZN's ROE is -0.00%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, ENZN is less volatile compared to CLVLF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs IDRSF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, IDRSF has a market cap of 337.12M. Regarding current trading prices, ENZN is priced at $0.09, while IDRSF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas IDRSF's P/E ratio is -0.85. In terms of profitability, ENZN's ROE is -0.00%, compared to IDRSF's ROE of +0.29%. Regarding short-term risk, ENZN is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs PRRUF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, PRRUF has a market cap of 321.29M. Regarding current trading prices, ENZN is priced at $0.09, while PRRUF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas PRRUF's P/E ratio is -11.00. In terms of profitability, ENZN's ROE is -0.00%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, ENZN is more volatile compared to PRRUF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs BOVNF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, BOVNF has a market cap of 309.28M. Regarding current trading prices, ENZN is priced at $0.09, while BOVNF trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas BOVNF's P/E ratio is -8.55. In terms of profitability, ENZN's ROE is -0.00%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, ENZN is more volatile compared to BOVNF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs PBBIF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, PBBIF has a market cap of 286.93M. Regarding current trading prices, ENZN is priced at $0.09, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, ENZN's ROE is -0.00%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, ENZN is less volatile compared to PBBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs ORYZF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, ORYZF has a market cap of 234.86M. Regarding current trading prices, ENZN is priced at $0.09, while ORYZF trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas ORYZF's P/E ratio is -43.29. In terms of profitability, ENZN's ROE is -0.00%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, ENZN is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs NWPHF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, NWPHF has a market cap of 231.22M. Regarding current trading prices, ENZN is priced at $0.09, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas NWPHF's P/E ratio is N/A. In terms of profitability, ENZN's ROE is -0.00%, compared to NWPHF's ROE of N/A. Regarding short-term risk, ENZN is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs MDCLF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, MDCLF has a market cap of 230.69M. Regarding current trading prices, ENZN is priced at $0.09, while MDCLF trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, ENZN's ROE is -0.00%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, ENZN is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs HLOSF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, HLOSF has a market cap of 228.29M. Regarding current trading prices, ENZN is priced at $0.09, while HLOSF trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas HLOSF's P/E ratio is -6.82. In terms of profitability, ENZN's ROE is -0.00%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, ENZN is less volatile compared to HLOSF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs SPHDF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, SPHDF has a market cap of 225.73M. Regarding current trading prices, ENZN is priced at $0.09, while SPHDF trades at $17.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas SPHDF's P/E ratio is -3.96. In terms of profitability, ENZN's ROE is -0.00%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, ENZN is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs RAONF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, RAONF has a market cap of 211.95M. Regarding current trading prices, ENZN is priced at $0.09, while RAONF trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas RAONF's P/E ratio is -20.33. In terms of profitability, ENZN's ROE is -0.00%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, ENZN is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs FPHAF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, FPHAF has a market cap of 209.54M. Regarding current trading prices, ENZN is priced at $0.09, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, ENZN's ROE is -0.00%, compared to FPHAF's ROE of N/A. Regarding short-term risk, ENZN is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs VSBC Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, VSBC has a market cap of 207.03M. Regarding current trading prices, ENZN is priced at $0.09, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas VSBC's P/E ratio is N/A. In terms of profitability, ENZN's ROE is -0.00%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, ENZN is more volatile compared to VSBC. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs FGHQF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, FGHQF has a market cap of 205.61M. Regarding current trading prices, ENZN is priced at $0.09, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, ENZN's ROE is -0.00%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, ENZN is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs HNSBF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, HNSBF has a market cap of 203.44M. Regarding current trading prices, ENZN is priced at $0.09, while HNSBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas HNSBF's P/E ratio is -2.34. In terms of profitability, ENZN's ROE is -0.00%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, ENZN is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs AVCTF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, AVCTF has a market cap of 199.39M. Regarding current trading prices, ENZN is priced at $0.09, while AVCTF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas AVCTF's P/E ratio is -4.33. In terms of profitability, ENZN's ROE is -0.00%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, ENZN is less volatile compared to AVCTF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs BSEM Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, BSEM has a market cap of 195.90M. Regarding current trading prices, ENZN is priced at $0.09, while BSEM trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas BSEM's P/E ratio is -25.51. In terms of profitability, ENZN's ROE is -0.00%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, ENZN is less volatile compared to BSEM. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs NGENF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, NGENF has a market cap of 182.35M. Regarding current trading prices, ENZN is priced at $0.09, while NGENF trades at $2.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas NGENF's P/E ratio is -9.85. In terms of profitability, ENZN's ROE is -0.00%, compared to NGENF's ROE of -2.23%. Regarding short-term risk, ENZN is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs GNFTF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, GNFTF has a market cap of 176.25M. Regarding current trading prices, ENZN is priced at $0.09, while GNFTF trades at $3.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas GNFTF's P/E ratio is 8.85. In terms of profitability, ENZN's ROE is -0.00%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, ENZN is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs SCNLF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, SCNLF has a market cap of 176.05M. Regarding current trading prices, ENZN is priced at $0.09, while SCNLF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas SCNLF's P/E ratio is -5.66. In terms of profitability, ENZN's ROE is -0.00%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, ENZN is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs OPORF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, OPORF has a market cap of 164.88M. Regarding current trading prices, ENZN is priced at $0.09, while OPORF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas OPORF's P/E ratio is 12.00. In terms of profitability, ENZN's ROE is -0.00%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, ENZN is less volatile compared to OPORF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs MLLCF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, MLLCF has a market cap of 155.61M. Regarding current trading prices, ENZN is priced at $0.09, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas MLLCF's P/E ratio is -2.19. In terms of profitability, ENZN's ROE is -0.00%, compared to MLLCF's ROE of -0.36%. Regarding short-term risk, ENZN is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs RECEF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, RECEF has a market cap of 149.84M. Regarding current trading prices, ENZN is priced at $0.09, while RECEF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas RECEF's P/E ratio is -10.00. In terms of profitability, ENZN's ROE is -0.00%, compared to RECEF's ROE of +2.26%. Regarding short-term risk, ENZN is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs IUGNF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, IUGNF has a market cap of 141.87M. Regarding current trading prices, ENZN is priced at $0.09, while IUGNF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas IUGNF's P/E ratio is -1.90. In terms of profitability, ENZN's ROE is -0.00%, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, ENZN is less volatile compared to IUGNF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs BRIBF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, BRIBF has a market cap of 134.10M. Regarding current trading prices, ENZN is priced at $0.09, while BRIBF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas BRIBF's P/E ratio is -1.83. In terms of profitability, ENZN's ROE is -0.00%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, ENZN is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs IPHYF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, IPHYF has a market cap of 133.63M. Regarding current trading prices, ENZN is priced at $0.09, while IPHYF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas IPHYF's P/E ratio is -2.10. In terms of profitability, ENZN's ROE is -0.00%, compared to IPHYF's ROE of -0.84%. Regarding short-term risk, ENZN is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs AAPGV Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, AAPGV has a market cap of 127.31M. Regarding current trading prices, ENZN is priced at $0.09, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas AAPGV's P/E ratio is N/A. In terms of profitability, ENZN's ROE is -0.00%, compared to AAPGV's ROE of N/A. Regarding short-term risk, ENZN is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs PRNAF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, PRNAF has a market cap of 126.87M. Regarding current trading prices, ENZN is priced at $0.09, while PRNAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas PRNAF's P/E ratio is -1.39. In terms of profitability, ENZN's ROE is -0.00%, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, ENZN is more volatile compared to PRNAF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs AMGXF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, AMGXF has a market cap of 121.79M. Regarding current trading prices, ENZN is priced at $0.09, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, ENZN's ROE is -0.00%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, ENZN is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs PSTTF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, PSTTF has a market cap of 117.53M. Regarding current trading prices, ENZN is priced at $0.09, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, ENZN's ROE is -0.00%, compared to PSTTF's ROE of N/A. Regarding short-term risk, ENZN is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs EPRXF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, EPRXF has a market cap of 108.29M. Regarding current trading prices, ENZN is priced at $0.09, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, ENZN's ROE is -0.00%, compared to EPRXF's ROE of -1.99%. Regarding short-term risk, ENZN is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs ADOIF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, ADOIF has a market cap of 103.66M. Regarding current trading prices, ENZN is priced at $0.09, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, ENZN's ROE is -0.00%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, ENZN is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs ADOCY Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, ADOCY has a market cap of 98.20M. Regarding current trading prices, ENZN is priced at $0.09, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, ENZN's ROE is -0.00%, compared to ADOCY's ROE of +1.28%. Regarding short-term risk, ENZN is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs TRGNF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, TRGNF has a market cap of 92.35M. Regarding current trading prices, ENZN is priced at $0.09, while TRGNF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas TRGNF's P/E ratio is -2.12. In terms of profitability, ENZN's ROE is -0.00%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, ENZN is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs CMVLF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, CMVLF has a market cap of 90.12M. Regarding current trading prices, ENZN is priced at $0.09, while CMVLF trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas CMVLF's P/E ratio is -3.05. In terms of profitability, ENZN's ROE is -0.00%, compared to CMVLF's ROE of -0.30%. Regarding short-term risk, ENZN is less volatile compared to CMVLF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs MCURF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, MCURF has a market cap of 86.53M. Regarding current trading prices, ENZN is priced at $0.09, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas MCURF's P/E ratio is -16.90. In terms of profitability, ENZN's ROE is -0.00%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, ENZN is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs PBIGF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, PBIGF has a market cap of 83.73M. Regarding current trading prices, ENZN is priced at $0.09, while PBIGF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas PBIGF's P/E ratio is -7.17. In terms of profitability, ENZN's ROE is -0.00%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, ENZN is less volatile compared to PBIGF. This indicates potentially lower risk in terms of short-term price fluctuations for ENZN.
ENZN vs ACHFF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, ACHFF has a market cap of 80.41M. Regarding current trading prices, ENZN is priced at $0.09, while ACHFF trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas ACHFF's P/E ratio is -30.50. In terms of profitability, ENZN's ROE is -0.00%, compared to ACHFF's ROE of +0.56%. Regarding short-term risk, ENZN is more volatile compared to ACHFF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs KNTPF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, KNTPF has a market cap of 77.03M. Regarding current trading prices, ENZN is priced at $0.09, while KNTPF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas KNTPF's P/E ratio is -3.55. In terms of profitability, ENZN's ROE is -0.00%, compared to KNTPF's ROE of -4.62%. Regarding short-term risk, ENZN is more volatile compared to KNTPF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.
ENZN vs ETXPF Comparison
ENZN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENZN stands at 6.35M. In comparison, ETXPF has a market cap of 75.96M. Regarding current trading prices, ENZN is priced at $0.09, while ETXPF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENZN currently has a P/E ratio of -8.55, whereas ETXPF's P/E ratio is -6.50. In terms of profitability, ENZN's ROE is -0.00%, compared to ETXPF's ROE of -0.36%. Regarding short-term risk, ENZN is more volatile compared to ETXPF. This indicates potentially higher risk in terms of short-term price fluctuations for ENZN.